[ad_1]
Even the bears are willing to give Palantir credit for its latest results — but they aren’t necessarily willing to change their view on the stock.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...